Production (Stage)
Connect Biopharma Holdings Limited
CNTB
$0.9301
-$0.0199-2.10%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 84.00M | 93.71M | 93.71M | 110.24M | 118.30M |
| Total Receivables | 175.00K | 1.05M | 1.05M | 3.56M | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.52M | 2.15M | 2.15M | 2.10M | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 65.00K | 53.00K | 53.00K | -- | -- |
| Total Current Assets | 87.76M | 96.96M | 96.96M | 115.90M | -- |
|
|
|||||
| Total Current Assets | 87.76M | 96.96M | 96.96M | 115.90M | -- |
| Net Property, Plant & Equipment | 4.84M | 4.24M | 4.24M | 4.52M | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 50.00K | 53.00K | 53.00K | 57.00K | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 45.00K | 33.00K | 33.00K | 96.00K | -- |
| Total Assets | 92.69M | 101.28M | 101.28M | 120.57M | -- |
|
|
|||||
| Total Accounts Payable | 817.00K | 342.00K | 342.00K | 5.70M | -- |
| Total Accrued Expenses | 7.24M | 7.55M | 7.55M | 3.16M | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 346.00K | 154.00K | 154.00K | 252.00K | -- |
| Total Finance Division Other Current Liabilities | 164.00K | 413.00K | 413.00K | 513.00K | -- |
| Total Other Current Liabilities | 164.00K | 413.00K | 413.00K | 513.00K | -- |
| Total Current Liabilities | 8.57M | 8.46M | 8.46M | 9.62M | -- |
|
|
|||||
| Total Current Liabilities | 8.57M | 8.46M | 8.46M | 9.62M | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 594.00K | 24.00K | 24.00K | 73.00K | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 627.00K | 632.00K | 632.00K | 394.00K | -- |
| Total Liabilities | 9.79M | 9.12M | 9.12M | 10.09M | -- |
|
|
|||||
| Common Stock & APIC | 440.31M | 439.37M | 439.37M | 628.88M | -- |
| Retained Earnings | -355.63M | -345.36M | -345.36M | -531.70M | -- |
| Treasury Stock & Other | -1.79M | -1.85M | -1.85M | 13.30M | -- |
| Total Common Equity | 82.90M | 92.17M | 92.17M | 110.48M | 101.50M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 82.90M | 92.17M | 92.17M | 110.48M | 101.50M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 82.90M | 92.17M | 92.17M | 110.48M | 101.50M |
|
|
|||||